University of Minnesota. Driven to Discover.
With resistance emerging to a limited set of treatment options, new drugs for invasive fungal infections are desperately needed.
About a quarter of the 200 colonized patients had clinical illness, including 27 with bloodstream infections.
If illness from the fungus becomes more common, "We are dealing with the potential for a highly resistant bug to really take off."
Also, the CDC said C auris has been isolated from 110 more patients hospitalized in three affected states.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.